Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for…

Biotechnology

US, Pasadena [HQ]

Summary
Fin. Reports
Financials
Leadership & Strategy
Government, Law & Regulation
Employees
More Analysis

ARWR/Leadership and Strategy

Risk Factors

SEC · Classified by custom FinBERT model

Risk factors are part of the management evaluation and are sourced directly via SEC filings (10-K, 10-Q - Item 1A).
They are very helpful to evaluate risks and at the same time to qualitatively assess the management.

By Management

10-K

Definition and Limitations of Internal Control over Financial Reporting
Opinion on Internal Control over Financial Reporting
Revenue Recognition – Revenue Recognized Over Time

5 more risks